$-0.27 EPS Expected for ViewRay, Inc. (VRAY)
March 10, 2018 – By Maria Brooks
Analysts expect ViewRay, Inc. (NASDAQ:VRAY) to report $-0.27 EPS on March, 15.They anticipate $0.02 EPS change or 8.00 % from last quarter’s $-0.25 EPS. After having $-0.19 EPS previously, ViewRay, Inc.’s analysts see 42.11 % EPS growth. The stock increased 2.23% or $0.18 during the last trading session, reaching $8.24. About 605,798 shares traded. ViewRay, Inc. (NASDAQ:VRAY) has risen 34.94% since March 10, 2017 and is uptrending. It has outperformed by 18.24% the S&P500.
ViewRay, Inc., through its subsidiary, ViewRay Technologies, Inc., designs, makes, and markets radiation therapy systems. The company has market cap of $615.89 million. It offers MRIdian, a radiation therapy solution that enables treatment and real-time imaging of a patient's anatomy simultaneously. It currently has negative earnings. MRIdian integrates MRI technology, radiation delivery, and proprietary software to locate, target, and track the position and shape of soft-tissue tumors while radiation is delivered.
More recent ViewRay, Inc. (NASDAQ:VRAY) news were published by: Streetinsider.com which released: “Form 4 ViewRay, Inc. For: Mar 01 Filed by: Moore Daniel Jeffrey” on March 06, 2018. Also Crainscleveland.com published the news titled: “ViewRay Inc. to raise about $59 million through sale of stock and warrants” on February 26, 2018. Prnewswire.com‘s news article titled: “ViewRay Announces Conference Call and Webcast of Fourth Quarter and Full Year …” with publication date: March 06, 2018 was also an interesting one.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.